Santhera’s DMD therapy Agamree approved for NHS use after new price deal
An improved price discount and new evidence from Santhera has changed NICE’s tune following a recommendation shun earlier this year.
An improved price discount and new evidence from Santhera has changed NICE’s tune following a recommendation shun earlier this year.
What's Your Reaction?
